0001179110-21-009894.txt : 20211105 0001179110-21-009894.hdr.sgml : 20211105 20211105160143 ACCESSION NUMBER: 0001179110-21-009894 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211103 FILED AS OF DATE: 20211105 DATE AS OF CHANGE: 20211105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McCain Tracey L CENTRAL INDEX KEY: 0001683600 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37359 FILM NUMBER: 211384425 MAIL ADDRESS: STREET 1: C/O BLUEPRINTS MEDICINES CORPORATION STREET 2: 38 SIDNEY STREET, SUITE 200 CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Blueprint Medicines Corp CENTRAL INDEX KEY: 0001597264 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 45 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-374-7580 MAIL ADDRESS: STREET 1: 45 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 edgar.xml FORM 4 - X0306 4 2021-11-03 0 0001597264 Blueprint Medicines Corp BPMC 0001683600 McCain Tracey L C/O BLUEPRINT MEDICINES CORPORATION 45 SIDNEY STREET CAMBRIDGE MA 02139 0 1 0 0 EVP and Chief Legal Officer Common Stock 2021-11-03 4 M 0 5000 28.36 A 38274 D Common Stock 2021-11-03 4 S 0 4200 110.74 D 34074 D Common Stock 2021-11-03 4 S 0 800 109.63 D 33274 D Stock Option (Right to Buy) 28.36 2021-11-03 4 M 0 5000 0 D 2026-10-03 Common Stock 5000 60000 D Effected pursuant to a trading plan adopted on February 22, 2021 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.23 to $111.09 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.39 to $109.96 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. This option was granted on October 3, 2016 and fully vested as of the date hereof. /s/ Ariel Hurley, Attorney-in-Fact 2021-11-05